메뉴 건너뛰기




Volumn 277, Issue 3, 1996, Pages 1659-1664

The biotransformation of clomipramine in vitro, identification of the cytochrome P450s responsible for the separate metabolic pathways

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CITALOPRAM; CLOMIPRAMINE; CYTOCHROME P450; DRUG METABOLITE; FLUOXETINE; FLUVOXAMINE; KETOCONAZOLE; MEPHENYTOIN; MOCLOBEMIDE; NORFLUOXETINE; PAROXETINE; QUINIDINE; SERTRALINE;

EID: 0030425332     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (97)

References (45)
  • 1
    • 9544249708 scopus 로고
    • Desipramine Pharmacokinetics with the Serotonin Reuptake Inhibitors, Paroxetine or Sertraline
    • Abstract presented 26 June to 1 July, Washington
    • ALDERMAN, J., GREENBLATT, D. J., ALLISON, J., PRESKORN, S. H., CHUNG, M. AND HARRISON, W.: Desipramine Pharmacokinetics with the Serotonin Reuptake Inhibitors, Paroxetine or Sertraline, Abstract presented at the XIX CINP Congress, 26 June to 1 July, Washington, 1994.
    • (1994) XIX CINP Congress
    • Alderman, J.1    Greenblatt, D.J.2    Allison, J.3    Preskorn, S.H.4    Chung, M.5    Harrison, W.6
  • 2
    • 0024309378 scopus 로고
    • Comparative effects of two antimycotic agents, ketoconazole and terbinafine, on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxyeoumarin by human liver microsomes in vitro
    • BACK, D. J., STEVENSON, P. AND TJIA, J. F.: Comparative effects of two antimycotic agents, ketoconazole and terbinafine, on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxyeoumarin by human liver microsomes in vitro. Br. J. Clin. Pharmacol. 28: 166-170, 1989.
    • (1989) Br. J. Clin. Pharmacol. , vol.28 , pp. 166-170
    • Back, D.J.1    Stevenson, P.2    Tjia, J.F.3
  • 3
    • 0027155665 scopus 로고
    • Grapefruit juice-felodipine interaction: Mechanism, predictability, and effect of naringin
    • BAILEY, D. G., ARNOLD, J. M. O., MUNOZ, C. AND SPENCE, J. D.: Grapefruit juice-felodipine interaction: Mechanism, predictability, and effect of naringin. Clin. Pharmacol. Ther. 53: 637-642, 1993.
    • (1993) Clin. Pharmacol. Ther. , vol.53 , pp. 637-642
    • Bailey, D.G.1    Arnold, J.M.O.2    Munoz, C.3    Spence, J.D.4
  • 4
    • 0022898438 scopus 로고
    • Importance of oxidative polymorphisms and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites
    • BALANT-GORGIA, A. E., BALANT, L. P., GENET, C. H., DAYER, P., AESCHLIMANN, J. M. AND GARRONNE, G.: Importance of oxidative polymorphisms and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites. Eur. J. Clin. Pharmacol. 31: 449-455, 1986.
    • (1986) Eur. J. Clin. Pharmacol. , vol.31 , pp. 449-455
    • Balant-Gorgia, A.E.1    Balant, L.P.2    Genet, C.H.3    Dayer, P.4    Aeschlimann, J.M.5    Garronne, G.6
  • 8
    • 0024359574 scopus 로고
    • Clinical significance of the sparteine/debrisoquine oxidation polymorphism
    • BRØSEN, K. AND GRAM, L. F.: Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur. J. Clin. Pharmacol. 36: 537-547, 1989.
    • (1989) Eur. J. Clin. Pharmacol. , vol.36 , pp. 537-547
    • Brøsen, K.1    Gram, L.F.2
  • 9
    • 0025829102 scopus 로고
    • Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine and mephenytoin
    • BRØSEN, K., GRAM, L. F. AND KRAGH-SØRENSEN, P.: Extremely slow metabolism of amitriptyline but normal metabolism of imipramine and desipramine in an extensive metabolizer of sparteine, debrisoquine and mephenytoin. Ther. Drug Monit. 13: 177-182, 1991a.
    • (1991) Ther. Drug Monit. , vol.13 , pp. 177-182
    • Brøsen, K.1    Gram, L.F.2    Kragh-Sørensen, P.3
  • 10
    • 0027167470 scopus 로고
    • Inhibition of paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine
    • BRØSEN, K., HANSEN, M. J. G., KRAMER NIELSEN, K., SINDRUP, S. H. AND GRAM, L. F.: Inhibition of paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine. Eur. J. Clin. Pharmacol. 44: 349-355, 1993a.
    • (1993) Eur. J. Clin. Pharmacol. , vol.44 , pp. 349-355
    • Brøsen, K.1    Hansen, M.J.G.2    Kramer Nielsen, K.3    Sindrup, S.H.4    Gram, L.F.5
  • 11
    • 0023032092 scopus 로고
    • Imipramine demethylation and hydroxylation: Impact of the sparteine oxidation phenotype
    • BRØSEN, K., OTTON, S. V. AND GRAM, L. F.: Imipramine demethylation and hydroxylation: Impact of the sparteine oxidation phenotype. Clin. Pharmacol. Ther. 40: 543-549, 1986.
    • (1986) Clin. Pharmacol. Ther. , vol.40 , pp. 543-549
    • Brøsen, K.1    Otton, S.V.2    Gram, L.F.3
  • 13
    • 0025733250 scopus 로고
    • Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine
    • BRØSEN, K., ZEUGIN, T. AND MEYER, U. A.: Role of P450IID6, the target of the sparteine-debrisoquin oxidation polymorphism, in the metabolism of imipramine. Clin. Pharmacol. Ther. 49: 609-617, 1991b.
    • (1991) Clin. Pharmacol. Ther. , vol.49 , pp. 609-617
    • Brøsen, K.1    Zeugin, T.2    Meyer, U.A.3
  • 14
    • 0026787192 scopus 로고
    • The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes
    • CREWE, H. K., LENNARD, M. S., TUCKER, G. T., WOODS, F. R. AND HADDOCK, R. E.: The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br. J. Clin. Pharmacol. 34: 262-265, 1992.
    • (1992) Br. J. Clin. Pharmacol. , vol.34 , pp. 262-265
    • Crewe, H.K.1    Lennard, M.S.2    Tucker, G.T.3    Woods, F.R.4    Haddock, R.E.5
  • 16
    • 12644288620 scopus 로고
    • Influence du sexe et du tabagisme sur les concentrations plasmatiques de la clomipramine, de l'amitriptyline et de leurs métabolites déméthylés
    • GOUEZO, F., ROP, P. P. AND VIALA, A.: Influence du sexe et du tabagisme sur les concentrations plasmatiques de la clomipramine, de l'amitriptyline et de leurs métabolites déméthylés. J. Toxicol. Clin. Exp. 8: 39-46, 1988.
    • (1988) J. Toxicol. Clin. Exp. , vol.8 , pp. 39-46
    • Gouezo, F.1    Rop, P.P.2    Viala, A.3
  • 17
    • 0025757011 scopus 로고
    • Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples
    • GUENGERICH, F. P. ANND TURVEY, C. G.: Comparison of levels of several human microsomal cytochrome P450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256: 1189-1194, 1990.
    • (1990) J. Pharmacol. Exp. Ther. , vol.256 , pp. 1189-1194
    • Guengerich, F.P.1    Turvey, C.G.2
  • 18
    • 0027401927 scopus 로고
    • Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients
    • HÄRTTER, S., WETZEL, H., HAMMES, E. AND HIEMKE, C.: Inhibition of antidepressant demethylation and hydroxylation by fluvoxamine in depressed patients. Psychopharmacology 110: 302-308, 1993.
    • (1993) Psychopharmacology , vol.110 , pp. 302-308
    • Härtter, S.1    Wetzel, H.2    Hammes, E.3    Hiemke, C.4
  • 20
    • 0019185720 scopus 로고
    • Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing
    • JOHN, V. A., LUSCOMBE, D. K. AND KEMP, H.: Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing. J. Int. Med. Res. 8: 88-95, 1980.
    • (1980) J. Int. Med. Res. , vol.8 , pp. 88-95
    • John, V.A.1    Luscombe, D.K.2    Kemp, H.3
  • 21
    • 0027538491 scopus 로고
    • High-performance liquid chromatography of clomipramine and metabolites in human plasma and urine
    • KRAMER NIELSEN, K. AND BRØSEN, K.: High-performance liquid chromatography of clomipramine and metabolites in human plasma and urine. Ther. Drug Monit. 15: 122-128, 1993.
    • (1993) Ther. Drug Monit. , vol.15 , pp. 122-128
    • Kramer Nielsen, K.1    Brøsen, K.2
  • 22
    • 0026739661 scopus 로고
    • Steady-state plasma levels of clomipramine and its metabolites: Impact of the sparteine/debrisoquine oxidation polymorphism
    • KRAMER NIELSEN, K., BRØSEN, K., GRAM, L. F. AND DANISH UNIVERSITY ANTIDEPRESSANT GROUP: Steady-state plasma levels of clomipramine and its metabolites: Impact of the sparteine/debrisoquine oxidation polymorphism. Eur. J. Clin. Pharmacol. 43: 405-411, 1992.
    • (1992) Eur. J. Clin. Pharmacol. , vol.43 , pp. 405-411
    • Kramer Nielsen, K.1    Brøsen, K.2    Gram, L.F.3
  • 23
    • 0028303496 scopus 로고
    • Single-dose kinetics of clomipramine: Relationship to the sparteine and S-mephenytoin oxidation polymorphisms
    • KRAMER NIELSEN, K., BRØSEN, K., HANSEN, M. G. J. AND GRAM, L. F.: Single-dose kinetics of clomipramine: Relationship to the sparteine and S-mephenytoin oxidation polymorphisms. Clin. Pharmacol. Ther. 55: 518-527, 1994a.
    • (1994) Clin. Pharmacol. Ther. , vol.55 , pp. 518-527
    • Kramer Nielsen, K.1    Brøsen, K.2    Hansen, M.G.J.3    Gram, L.F.4
  • 24
    • 0028044040 scopus 로고
    • Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype
    • KRAMER NIELSEN, K., BRØSEN, K., HANSEN, M. G. J. AND GRAM, L. F.: Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotype. Eur. J. Clin. Pharmacol. 47: 209-210, 1994b.
    • (1994) Eur. J. Clin. Pharmacol. , vol.47 , pp. 209-210
    • Kramer Nielsen, K.1    Brøsen, K.2    Hansen, M.G.J.3    Gram, L.F.4
  • 28
    • 0020635141 scopus 로고
    • Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation
    • MEIER, P. J., MUELLER, H. K., DICK, B. AND MEYER, U. A.: Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation. Gastroenterology 85: 682-692, 1983.
    • (1983) Gastroenterology , vol.85 , pp. 682-692
    • Meier, P.J.1    Mueller, H.K.2    Dick, B.3    Meyer, U.A.4
  • 31
    • 0021345446 scopus 로고
    • Competitive inhibition of sparteine oxidation in human liver beta adrenoceptor antagonists and other cardiovascular drugs
    • OTTON, S. V., INABA, T. AND KALOW, W.: Competitive inhibition of sparteine oxidation in human liver beta adrenoceptor antagonists and other cardiovascular drugs. Life Sci. 34: 73-80, 1984.
    • (1984) Life Sci. , vol.34 , pp. 73-80
    • Otton, S.V.1    Inaba, T.2    Kalow, W.3
  • 33
    • 0028898044 scopus 로고
    • Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: Potent inhibition by fluvoxamine
    • RASMUSSEN, B. B., MÄENPÄÄ, J., PELKONEN, O., LOFT, S., POULSEN, H. E., LYKKESFELDT, J. AND BRØSEN, K.: Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: Potent inhibition by fluvoxamine. Br. J. Clin. Pharmacol. 39: 151-159, 1995.
    • (1995) Br. J. Clin. Pharmacol. , vol.39 , pp. 151-159
    • Rasmussen, B.B.1    Mäenpää, J.2    Pelkonen, O.3    Loft, S.4    Poulsen, H.E.5    Lykkesfeldt, J.6    Brøsen, K.7
  • 35
    • 0025670512 scopus 로고
    • Expression of human liver cytochrome P-450IIIA in yeast: A functional model for the hepatic enzyme
    • RENAUD, J. P., CULLIN, C., POMPON, P., BEAUNE, P. AND MANSUY, D.: Expression of human liver cytochrome P-450IIIA in yeast: A functional model for the hepatic enzyme. Eur. J. Biochem. 194: 889-896, 1990.
    • (1990) Eur. J. Biochem. , vol.194 , pp. 889-896
    • Renaud, J.P.1    Cullin, C.2    Pompon, P.3    Beaune, P.4    Mansuy, D.5
  • 36
    • 0023687412 scopus 로고
    • A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking
    • SESARDIC, D., BOOBIS, A. R., EDWARDS, R. J. AND DAVIES, D. S.: A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26: 363-372, 1988.
    • (1988) Br. J. Clin. Pharmacol. , vol.26 , pp. 363-372
    • Sesardic, D.1    Boobis, A.R.2    Edwards, R.J.3    Davies, D.S.4
  • 37
    • 0028237729 scopus 로고
    • Inter-individual variations in human liver cytochrome P450 enzymes involved in the oxidations of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 caucasians
    • SHIMADA, T., YAMAZAKI, H., MIMURA, M., INUI, Y. AND GUENGERICH, F. P.: Inter-individual variations in human liver cytochrome P450 enzymes involved in the oxidations of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 caucasians. J. Pharmacol. Exp. Ther. 270: 414-423, 1994.
    • (1994) J. Pharmacol. Exp. Ther. , vol.270 , pp. 414-423
    • Shimada, T.1    Yamazaki, H.2    Mimura, M.3    Inui, Y.4    Guengerich, F.P.5
  • 38
    • 0025076711 scopus 로고
    • Non-linear kinetics of imipramine in low and medium plasma level ranges
    • SINDRUP, S. H., BRØSEN, K. AND GRAM, L. F.: Non-linear kinetics of imipramine in low and medium plasma level ranges. Ther. Drug Monit. 12: 445-449, 1990.
    • (1990) Ther. Drug Monit. , vol.12 , pp. 445-449
    • Sindrup, S.H.1    Brøsen, K.2    Gram, L.F.3
  • 39
    • 0027472058 scopus 로고
    • Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphism
    • SINDRUP, S. H., BRØSEN, K., HANSEN, M. G. J., AAES-JØRGENSEN, T., OVERØ, K. F. AND GRAM, L. F.: Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphism. Ther. Drug Monit. 15: 11-17, 1993.
    • (1993) Ther. Drug Monit. , vol.15 , pp. 11-17
    • Sindrup, S.H.1    Brøsen, K.2    Hansen, M.G.J.3    Aaes-Jørgensen, T.4    Overø, K.F.5    Gram, L.F.6
  • 40
    • 0026795695 scopus 로고
    • Inhibitors of imipramine metabolism by human liver microsomes
    • SKJELBO, E. AND BRØSEN, K.: Inhibitors of imipramine metabolism by human liver microsomes. Br. J. Clin. Pharmacol. 34: 256-261, 1992.
    • (1992) Br. J. Clin. Pharmacol. , vol.34 , pp. 256-261
    • Skjelbo, E.1    Brøsen, K.2
  • 41
    • 0025964524 scopus 로고
    • The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine
    • SKJELBO, E., BRØSEN, K., HALLAS, J. AND GRAM, L. F.: The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine. Clin. Pharmacol. Ther. 49: 18-23, 1991.
    • (1991) Clin. Pharmacol. Ther. , vol.49 , pp. 18-23
    • Skjelbo, E.1    Brøsen, K.2    Hallas, J.3    Gram, L.F.4
  • 42
    • 0027254118 scopus 로고
    • Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects
    • SPINA, E., POLLICINO, A. M., AVENOSO, A., CAMPO, G. M., PERUCCA, E. AND CAPUTI, A. P.: Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects. Ther. Drug Monit. 15: 243-246, 1993.
    • (1993) Ther. Drug Monit. , vol.15 , pp. 243-246
    • Spina, E.1    Pollicino, A.M.2    Avenoso, A.3    Campo, G.M.4    Perucca, E.5    Caputi, A.P.6
  • 44
    • 0020080162 scopus 로고
    • Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response
    • VANDEL, B., VANDEL, S., JOUNET, J. M., ALLERS, G. AND VOLMAT, R.: Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response. Eur. J. Clin. Pharmacol. 22: 15-20, 1982.
    • (1982) Eur. J. Clin. Pharmacol. , vol.22 , pp. 15-20
    • Vandel, B.1    Vandel, S.2    Jounet, J.M.3    Allers, G.4    Volmat, R.5
  • 45
    • 0027445449 scopus 로고
    • Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylation
    • WRIGHTON, S. A., STEVENS, J. C., BECKER, G. W. AND VANDENBRANDEN, M.: Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4′-hydroxylation. Arch. Biochem. Biophys. 306: 240-245, 1993.
    • (1993) Arch. Biochem. Biophys. , vol.306 , pp. 240-245
    • Wrighton, S.A.1    Stevens, J.C.2    Becker, G.W.3    Vandenbranden, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.